Medical News

RSS

Winner of 2010 European Magnetic Resonance Award

Dr John Griffiths, a Cancer Research UK-funded scientist, has received the 2010 European Magnetic Resonance Award for Basic Sciences.

20 Mar 2010

Lexicon Pharmaceuticals completes public offering and concurrent private placement of common stock

Lexicon Pharmaceuticals, Inc. today announced the completion of its previously-announced public offering and concurrent private placement of its common stock, resulting in net proceeds to Lexicon of approximately $181.4 million after the exercise in full by the underwriters of their over-allotment option and by Invus, L.P., Lexicon's largest stockholder, of its associated right to purchase additional shares.

20 Mar 2010

Obama, Dem leaders confident about health reform legislation

The Wall Street Journal / Dow Jones: "House Democratic leaders expressed confidence Friday that they would have enough votes to pass health-care legislation, picking up one new 'yes' vote and promising that they would resolve lingering concerns raised by undecided Democrats." A House vote is planned for Sunday.

20 Mar 2010

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

LiftSeat Corporation, a leading healthcare toileting solutions company, is now the exclusive distributor in the United States of the Hygie Hygienic Cover System, which is proven to help prevent the spread of potentially fatal healthcare-associated infections. The joint announcement was made today at the Fifth Decennial International Conference on Healthcare-Associated Infections 2010.

20 Mar 2010

KHN columns explore how abortion funding issues are factoring into health reform

In one Kaiser Health News column, Jessica Arons writes: "In an attempt to keep health reform from being torpedoed by the ever-contentious topic of abortion, advocates and opponents of abortion rights were expected to agree that legislation would preserve the "status quo" on abortion law and not be used to advance or restrict abortion rights.

20 Mar 2010

Report highlights gains in malaria fight, documents need for more funding

Global funding for efforts to fight malaria, which stood at $2 billion at the end of 2009, have "helped to contain the disease," but is "far short of the estimated $6 billion required annually to expand" efforts to fight it, the Roll Back Malaria Partnership said on Thursday, Reuters reports. The statements came as the partnership released a report (.pdf) that examined a decade's worth of global funding for malaria and its impact on fighting the disease (Hardach, 3/18).

20 Mar 2010

High dose of Zocor could lead to muscle injury, warns FDA

The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg.

20 Mar 2010

Drug company fights for patent extension

The New York Times: The drug maker Medicines Company that makes the blood thinner called Angiomax, missed the application deadline to extend its patent back in 2000 by a day or two, depending on how you count.

20 Mar 2010

ELCA's 49-page draft social statement on genetics

The Evangelical Lutheran Church in America released March 18 a 49-page draft social statement on genetics, a framework for discussion on a variety of current topics in the field including certain advances in medicine, reproductive cloning, human embryonic stem cells, and animal and plant genetic engineering.

20 Mar 2010

Details of Democratic tweaks to health bill

News reports scour the latest health overhaul bill for specific provisions and adjustments.

20 Mar 2010

BCBSAZ recognized with Brand Excellence Award in Enrollment Growth category

Blue Cross Blue Shield of Arizona announced today that it has received a Brand Excellence Award from the Blue Cross and Blue Shield Association. The annual awards honor Blue Cross and Blue Shield companies that excel in developing and enhancing the overall Blue Cross and Blue Shield brand image.

20 Mar 2010

DARA BioSciences receives NASDAQ non-compliance notice

On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.

20 Mar 2010

CCAGW calls upon Congress to vote against healthcare bill

The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation’s healthcare system using parliamentary gimmicks and urged members to vote against the bill.

20 Mar 2010

Canadian Prime Minister says he's open to including contraception in G8 plan for improving maternal, child health

"Facing a squall of condemnation from aid groups and opposition politicians," following statements by Canadian Foreign Minister Lawrence Cannon that Canada's G8 maternal and child health initiative would not include family planning, Prime Minister Stephen Harper "disavowed his foreign minister Thursday, promising that the federal government would include contraception programs in its maternal-health foreign-aid initiative," the Globe and Mail reports.

20 Mar 2010

NYBC joins "Honor Roll of Life" of US blood centers to support Haiti relief effort

New York Blood Center, serving New York City, Long Island, the Hudson Valley, and New Jersey, has provided a contribution of $76,250, and has joined the "Honor Roll of Life" of US blood centers providing units of blood directly to the Haiti relief effort.

20 Mar 2010

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association.

20 Mar 2010

CBO numbers buoy Democrats eyeing Sunday health reform vote

Democrats unveiled a health overhaul reconciliation bill the Congressional Budget Office says will cost $940 billion but also cut the deficit by $138 billion over the next 10 years.

20 Mar 2010

Susan G. Komen receives $31,680 as donation for the Cure, San Diego

The Associates of AimLoan.com, a San Diego based Internet Direct Lender, announced a generous donation to Susan G. Komen for the Cure, San Diego for a total of $31,680. This contribution positions the organization as the second largest corporate donor in San Diego. The donation is a result of their 4th Quarter 2009 Community Service Website Campaign.

20 Mar 2010

'Cadillac' insurance plans explained

Kaiser Health News staff writer Jenny Gold, in collaboration with NPR, provides an update to explain the latest on how these high-cost insurance plans are treated in the latest health reform package.

20 Mar 2010

Innovative tissue damage preventing cardiac scaffold awarded Rappaport Prize for biomedical research

Prof. Smadar Cohen, head of the University's Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, has been awarded the prestigious Rappaport Prize for Excellence in Biomedical Research, an award totaling $100,000. The prize, given by Israel's Rappaport Foundation, is presented annually to a researcher whose research has either significantly advanced or has the potential to significantly advance any medical or biomedical field.

20 Mar 2010